GT Apeiron Therapeutics is based in San Francisco Bay Area. It has raised $18M in total funding. Latest round: Series A.
GT Apeiron Therapeutics is based in San Francisco Bay Area. GT Apeiron Therapeutics has raised $18M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in January 1970. The round record for GT Apeiron Therapeutics runs through 1970; nothing later has been disclosed. Investors on record include Panacea Venture, Viva BioInnovator. 2 distinct backers are named across the disclosed rounds.
Every GT Apeiron Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco Bay Area at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026